EXHIBIT 11. STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
| Three Months Ended | ||||||||
| March 31, | ||||||||
| 2007 | 2006 | |||||||
BASIC |
||||||||
Net income |
$ | 508.7 | $ | 834.8 | ||||
Average number of common shares outstanding |
1,088.4 | 1,085.2 | ||||||
Contingently issuable shares |
1.3 | .8 | ||||||
Adjusted average shares |
1,089.7 | 1,086.0 | ||||||
Basic earnings per share |
$ | .47 | $ | .77 | ||||
DILUTED |
||||||||
Net income |
$ | 508.7 | $ | 834.8 | ||||
Average number of common shares outstanding |
1,088.4 | 1,085.2 | ||||||
Incremental shares – stock options and
contingently issuable shares |
1.5 | 1.8 | ||||||
Adjusted average shares |
1,089.9 | 1,087.0 | ||||||
Diluted earnings per share |
$ | .47 | $ | .77 | ||||
Dollars and shares in millions except per-share data.